Goedegebuure Madeleine, Bury Matthew I, Wang Xinlong, Sanfelice Pasquale, Cammarata Federico, Wang Larry, Sharma Tiffany T, Rajinikanth Nachiket, Karra Vikram, Siddha Vidhika, Sharma Arun K, Ameer Guillermo A
Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Center for Advanced Regenerative Engineering, Northwestern University, Chicago, IL, USA.
Bioact Mater. 2024 Aug 16;41:553-563. doi: 10.1016/j.bioactmat.2024.07.030. eCollection 2024 Nov.
Chronic bladder dysfunction due to bladder disease or trauma is detrimental to affected patients as it can lead to increased risk of upper urinary tract dysfunction. Current treatment options include surgical interventions that enlarge the bladder with autologous bowel tissue to alleviate pressure on the upper urinary tract. This highly invasive procedure, termed bladder augmentation enterocystoplasty (BAE), significantly increases the risk of patient morbidity and mortality due to the incompatibility between bowel and bladder tissue. Therefore, patients would significantly benefit from an alternative treatment strategy that can regenerate healthy tissue and restore overall bladder function. Previous research has demonstrated the potential of citrate-based scaffolds co-seeded with bone marrow-derived stem/progenitor cells as an alternative graft for bladder augmentation. Recognizing that contact guidance can potentially influence tissue regeneration, we hypothesized that microtopographically patterned scaffolds would modulate cell responses and improve overall quality of the regenerated bladder tissue. We fabricated microgrooved (MG) scaffolds using the citrate-based biomaterial poly (1,8-octamethylene-citrate-octanol) (POCO) and co-seeded them with human bone marrow-derived mesenchymal stromal cells (MSCs) and CD34 hematopoietic stem/progenitor cells (HSPCs). MG POCO scaffolds supported MSC and HSPC attachment, and MSC alignment within the microgrooves. All scaffolds were characterized and assessed for bladder tissue regeneration in an established nude rat bladder augmentation model. In all cases, normal physiological function was maintained post-augmentation, even without the presence of stem/progenitor cells. Urodynamic testing at 4-weeks post-augmentation for all experimental groups demonstrated that bladder capacity increased and bladder compliance was normal. Histological evaluation of the regenerated tissue revealed that cell-seeded scaffolds restored normal bladder smooth muscle content and resulted in increased revascularization and peripheral nerve regeneration. The presence of microgrooves on the cell-seeded scaffolds increased microvasculature formation by 20 % and urothelial layer thickness by 25 % in the regenerating tissue. Thus, this work demonstrates that microtopography engineering can influence bladder tissue regeneration to improve overall anatomical structure and re-establish bladder physiology.
由于膀胱疾病或创伤导致的慢性膀胱功能障碍对受影响的患者有害,因为它会导致上尿路功能障碍的风险增加。目前的治疗选择包括手术干预,即使用自体肠组织扩大膀胱以减轻对上尿路的压力。这种高度侵入性的手术,称为膀胱扩大肠囊成形术(BAE),由于肠组织和膀胱组织之间的不相容性,显著增加了患者发病和死亡的风险。因此,患者将从能够再生健康组织并恢复膀胱整体功能的替代治疗策略中显著受益。先前的研究表明,与骨髓来源的干/祖细胞共接种的柠檬酸盐基支架作为膀胱扩大的替代移植物具有潜力。认识到接触引导可能会潜在地影响组织再生,我们假设微拓扑图案化支架将调节细胞反应并改善再生膀胱组织的整体质量。我们使用柠檬酸盐基生物材料聚(1,8 - 亚辛基 - 柠檬酸盐 - 辛醇)(POCO)制造了微槽(MG)支架,并将它们与人骨髓来源的间充质基质细胞(MSCs)和CD34造血干/祖细胞(HSPCs)共接种。MG POCO支架支持MSC和HSPC附着,以及MSC在微槽内的排列。在已建立的裸鼠膀胱扩大模型中,对所有支架进行了表征并评估其膀胱组织再生情况。在所有情况下,扩大术后均维持了正常的生理功能,即使没有干/祖细胞的存在。所有实验组在扩大术后4周进行的尿动力学测试表明膀胱容量增加且膀胱顺应性正常。对再生组织的组织学评估显示,接种细胞的支架恢复了正常的膀胱平滑肌含量,并导致血管再生增加和周围神经再生。接种细胞的支架上微槽的存在使再生组织中的微血管形成增加了20%,尿路上皮层厚度增加了25%。因此,这项工作表明微拓扑工程可以影响膀胱组织再生,以改善整体解剖结构并重建膀胱生理功能。